LONDON, May 15, 2023 /PRNewswire/ — Acute repetitive seizures are an affliction that can strike fear into the hearts of those who suffer from them. These seizures are characterized by recurrent bouts of convulsions, muscle spasms, and loss of consciousness, all of which can happen multiple times in a short span of time. The condition can be extremely debilitating and can have a significant impact on an individual’s quality of life. With proper diagnosis, medication, and lifestyle changes, individuals can reduce the frequency and severity of their seizures, improving their overall health and well-being.
The Global Acute Repetitive Seizures Market research report by BrandEssence Market Research provides a comprehensive analysis of the current market trends, drivers, challenges, and opportunities in the industry. The report offers detailed insights into the market size, growth potential, and competitive landscape of the global acute repetitive seizures market. The report covers various segments of the market, including drug class, distribution channel, and geography, among others. It also provides a detailed analysis of the key players operating in the market, including their market share, financial performance, product offerings, and strategic initiatives.
Key Takeaways
- Global Acute Repetitive Seizures Market is anticipated to expand with a CAGR of 45.6% over 2022-2029.
- Growing prevalence of neurological disorders, surge in the geriatric population base, and the rising pervasiveness of other chronic are aiding industry expansion.
- By end user, the healthcare and pharmaceuticals segment are likely to accrue significant returns due to the growing patient pool affected with the target disorder.
- MEA is showcasing an upward trend in this industry owing to the growing prevalence of epilepsy, rising healthcare expenditure, and spurring medical research activities.
The Global Acute Repetitive Seizures Market was worth USD 559.03 million in 2022 and is anticipated to amass a valuation of USD 7754.69 million by 2029, registering a CAGR of 45.6% over the assessment timeline of 2022-2029.
Acute repetitive seizures are a type of seizure disorder characterized by recurrent, unprovoked seizures that occur in clusters over a short period of time. These seizures typically last for a few seconds to a few minutes and can occur several times a day, or even several times an hour, for several days or weeks. Acute repetitive seizures can be caused by a variety of factors, including head injuries, strokes, brain tumors, infections, and genetic factors. Treatment for acute repetitive seizures typically involves anti-epileptic medications and, in some cases, surgery to remove the affected area of the brain.
Get Sample of [email protected] https://brandessenceresearch.com/downloadSample/PostId/2214
Elaborating the key trends and dynamics of the Acute Repetitive Seizures Market
Growing prevalence of neurological disorders, surge in the geriatric population base, and the rising pervasiveness of other chronic disorders like cancer are primarily augmenting the outlook of this business sphere. Furthermore, rapidly improving healthcare infrastructure, surging R&D investments in the field, along with the prompt technological advancements in the field are adding momentum to the progression of this marketplace. Moreover, increased healthcare expenditure worldwide and surging cognizance about these seizures are aiding the expansion of this business space.
Major growth drivers
Growing prevalence of epilepsy- There has been a growing prevalence of epilepsy worldwide. This is predominantly credited to genetic predisposition, brain injuries, infections, and stroke. Acute repetitive seizures are often associated with epilepsy. This has escalated the demand for effective treatment options for acute repetitive seizures. These factors together are stimulating the overall dynamics of this business vertical.
Escalating demand for personalized medicine- The growing demand for personalized medicine is a significant driver for the acute repetitive seizures market. Personalized medicine involves using patient-specific information to determine the best treatment approach for the individual patient. This approach is becoming increasingly important in the treatment of acute repetitive seizures, as there is no one-size-fits-all approach to treating this condition.
Challenges
Lesser understanding of the underlying causes: Despite advances in the diagnosis and treatment of acute repetitive seizures, there is still a limited understanding of the underlying causes of the condition. This can lead to difficulties in developing effective treatments and limit the growth of the market.
Competitive Landscape of Acute Repetitive Seizures Market
The prominent players defining the competitive terrain of the Global Acute Repetitive Seizures Market are Alexza Pharmaceuticals, Bausch Health, Neurelis Inc., Pfizer Inc., Sanofi, UCB S.A., Veriton Pharma, Valeant Pharmaceuticals North America LLC, Grupo Ferrer Internacional S.A., and Others.
Segmental Assessment
By product type, USL-261 segment is reckoned to amass notable gains over the analysis timeline of 2022-2029. This is due to its ease of use, as it can be administered by a caregiver without the need for an injection, as well as its fast onset of action.
Based on end user, the healthcare and pharmaceuticals segment are likely to accrue significant returns. This is ascribed to the growing patient pool affected with the target disorder.
Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/2214
Geographical Analysis & Landscape
Middle East & Africa Acute Repetitive Seizures Market
MEA is anticipated to showcase an upward trend in this industry. This is attributable to the growing prevalence of epilepsy, rising healthcare expenditure, and spurring medical research activities. Furthermore, increased awareness about neurological disorders and rising R&D investments in the field are propelling the overall growth of this regional market.
Asia Pacific
The Asia Pacific region is expected to experience significant growth in the acute repetitive seizures market due to several factors. One of the major factors driving the growth is the high prevalence of epilepsy in the region, particularly in countries such as China and India. Additionally, the increasing awareness about the availability of effective treatments and the rising healthcare expenditure in the region are expected to contribute to the growth of the market. Moreover, the presence of a large patient pool and the growing geriatric population are expected to further boost the demand for treatments for acute repetitive seizures in the Asia Pacific region.
Opportunities
Advancements in technology and drug development: The development of new and improved drugs and medical devices for the treatment of acute repetitive seizures is expected to fuel the growth of the market. Advancements in technology have also led to the development of non-invasive neuromodulation therapies, which offer a potential treatment option for patients with acute repetitive seizures.
Restraints
High cost of treatment: The high cost of treatment for acute repetitive seizures, including the cost of medications and devices, can be a significant barrier to access for patients, particularly in developing countries. This can restrict the growth of the market.
Major Developments in Acute Repetitive Seizures Market
Acquisitions
In November 2020, Marinus Pharmaceuticals announced its acquisition of Neuropathix, Inc., a privately held biopharmaceutical company focused on developing novel therapeutics for the treatment of pain and neurologic disorders, including acute repetitive seizures.
In September 2020, UCB announced its acquisition of Engage Therapeutics, a clinical-stage biopharmaceutical company developing a nasal spray formulation of midazolam for the treatment of acute repetitive seizures in patients with epilepsy.
Partnership
In July 2020, Ovid Therapeutics and Takeda Pharmaceutical Company Limited announced a global development and commercialization partnership for soticlestat (TAK-935/OV935), a potential treatment for rare epileptic encephalopathies, including some forms of acute repetitive seizures.
Acute Repetitive Seizures Market pipeline assessments:
NMDA receptor antagonists: These drugs block the activity of the NMDA receptors in the brain, which can help prevent seizures. Examples of NMDA receptor antagonists include ketamine and memantine.
GABA receptor agonists: GABA is an inhibitory neurotransmitter that helps regulate brain activity and prevent seizures. GABA receptor agonists enhance the activity of GABA in the brain and can help prevent seizures. Examples of GABA receptor agonists include benzodiazepines such as lorazepam and clonazepam.
Cannabinoids: Cannabinoids are compounds derived from the cannabis plant. Some cannabinoids, such as cannabidiol (CBD), have been shown to have anticonvulsant properties and may be effective in treating acute repetitive seizures.
Vagus nerve stimulation (VNS): VNS is a therapy in which a device is implanted in the chest that sends electrical impulses to the vagus nerve in the neck. These impulses can help reduce the frequency and severity of seizures.
Transcranial magnetic stimulation (TMS): TMS is a non-invasive therapy in which magnetic pulses are delivered to the brain to stimulate or inhibit brain activity. TMS has been shown to be effective in reducing seizure frequency in some patients.
Porter’s Five Forces Analysis
Threat of new entrants: The threat of new entrants to the market is low due to high regulatory barriers and the need for substantial investment in research and development.
Bargaining power of suppliers: The bargaining power of suppliers in the acute repetitive seizures market is moderate. This is because there are a limited number of suppliers, but they are highly specialized in the production of seizure medications.
Bargaining power of buyers: The bargaining power of buyers is high in this market, as patients have access to a wide range of treatment options and can switch between medications based on their preferences and tolerances.
Threat of substitutes: The threat of substitutes is moderate in this market, as there are a number of different medications and treatment options available for acute repetitive seizures.
Competitive rivalry: The competitive rivalry in the acute repetitive seizures market is high, with a large number of pharmaceutical companies vying for market share. However, the market is dominated by a few major players with established products and strong brand recognition.
On Special Requirement Acute Repetitive Seizures Market Report is also available for below region:
North America
Europe
- Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe
Asia-Pacific
- South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC
Latin America
- Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America
Middle East and Africa
- Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA
Purchase Copy of Report @ https://brandessenceresearch.com/Checkout?report_id=2214
Related Reports:
- Plasma Protein Therapeutics Market Size Growing at 7.15% CAGR, Set to Reach USD 44.79 billion by 2029 says Brandessence Market Research
- Cystic Fibrosis Therapeutics Market Forecast 2022-2029: Demand, Business Growth, Opportunity, Application, Cost, Sales, Service, End-Use, Size, Top Manufacturers Analysis – AbbVie Inc., Gilead Sciences, Inc., Novartis International AG, Vertex Pharmaceuticals Incorporated| Brandessence Market Research
- Global Home Diagnostics Market Growth, Size, Opportunities, Industry Analysis and Forecast 2022 To 2029
- Orthokeratology Lens Market Size, Share, Landscape, Industry Analysis, Business Outlook, Current and Future Growth by 2029 | Bausch & Lomb Inc., Euclid Systems Corp., Johnson & Johnson Vision Care, Inc.
- With 6.19% CAGR, Joint Reconstruction Market Size to Surpass USD 48.85 Billion by 2029 Says Brandessence Market Research
- Ulcerative Colitis Treatment Market Size 2023, SWOAT Analysis and Forecast To 2029 | Pfizer, Eli Lilly and Company, GSK, MSD | Brandessence Market Research
- Solid Tumor Market: Industry Trends & Outlook 2023 says Brandessence Market Research
- Global Artificial Intelligence in Breast Imaging Market to Project with 28.4% CAGR by 2029, says Brandessence Market Research
- 3D Cell Culture Market is Growing & will Touch the CAGR of 17.1% by the Year 2029 -Read Full Report | Brandessence Market Research
- Hip Replacement Implant Market Witness Excellent Long-Term Growth Outlook & Forecast 2029 | Brandessence Market Research
- Subscriptions and Recurring Payment Market is Foreseen to Grow at CAGR of +10% by 2029, Says Brandessence Market Research
- At CAGR of 14.9%, Game engine market is expected to reach ~$5.5 billion by 2025: Brandessence Market Research
- Canned Tuna Market Size 2023, SWOAT Analysis and Forecast To 2029 | American Tuna, Bumble Bee Foods, Dongwon Industries, Thai Union Group | Brandessence Market Research
- The Global Skin Care Product Market Expected to Grow by $180 Billion by 2026, According to Brandessence Market Research
- Global Powder Coatings Market: An Overview of Trends, Growth, and Opportunities Exclusive Report by Brandessence Market Research
- Global Beauty Supplements Market Value is Expected to Reach USD 4.6 Billion by 2028, says Brandessence Market Research
- Global Bioanalytical Services Market Size Expected to cross USD 2 Bn by 2028 says Brandessence Market Research
- Healthcare Specialty Enzymes Market to hit USD 6.84 billion by 2027, says Brandessence Market Research
- Global Polyclonal Antibodies Market to Project with +4% CAGR by 2029, says Brandessence Market Research
- Craniomaxillofacial Devices Market is to Hit $ 2.44 Billion by 2027, says Brandessence Market Research
- At 7.25% CAGR, Cycle Apparel Market Size is expected to generate a revenue of USD 7.41 Bn by 2029, Globally: Brandessence Market Research
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Follow Us: Linkedin
M & A Advisory: Merger & Acquisition, and Capabilities
Blog:
Published Reports 2023
What is Market Research?
What is Market Sizing? How to Measure Your TAM, SAM, and SOM
Top Self Driving Car Companies Revolutionizing the Mobility Vertical
The Future is Here: Location Intelligence Companies Leading the Charge
The Rise of Nutraceutical Companies: A New Era in Health and Wellness
Innovative Materials for a Better World: The Top Advanced Materials Companies You Need to Know About
The Future of Medicine: How Biochip Companies are Revolutionizing Healthcare
Bio-Innovations: Meet the Bioreactor Manufacturers Pioneering the Future of Manufacturing
Top Microalgae Companies You Need to Know About in 2023
From Bedside Tables to Waiting Room Chairs: The Best Hospital Furniture Manufacturers in the Business
Unleashing the Power of Neuromodulation: A Close Look at Spinal Cord Stimulation Companies
Top Business Process Management Companies to watch out for in 2023
Top 10 Frozen Potato Companies in 2023
Top 5 Natural Food Colors Companies in Global Market 2023 | Here’s Everything need to know About
Everything You Need to Know About the Top 5 Companies Operating in Global mRNA Vaccines and Therapeutics Market
The Rise of DIY Medicine: Exploring the Home Diagnostics Market
Top Activated Carbon Manufacturers in the Global Market 2023
Top 5 Skateboard Companies in Global Market 2023
Top 10 Healthcare Staffing Companies in Global Market 2023
TOP 5 Distributed Antenna System (DAS) COMPANIES 2023
Top 10 Plant-based Meat Companies : growing sustainable, plant-based food industry
Contact:
Mr. Vishal Sawant
Email: [email protected]
Email: [email protected]
Corporate Sales: +44-2038074155
Asia Office: +917447409162
Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg
SOURCE Brandessence Market Research And Consulting Private Limited
